VIVUS does not undertake an obligation to update or revise any forward-looking statement.
VIVUS不承担义务更新或修改任何前瞻性陈述。
2
These forward-looking statements are based on VIVUS' current expectations and actual results could differ materially.
这些前瞻性声明是基于VIVUS目前预期和实际结果可能大不相同。
3
In July, the FDA's expert panel recommended against another proposed diet drug, Qnexa, made by Vivus inc., because of safety issues that included heart palpitations.